As of May 27
| +0.18 / +9.33%|
The 3 analysts offering 12-month price forecasts for Xtant Medical Holdings Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 6.00. The median estimate represents a +373.93% increase from the last price of 2.11.
The current consensus among 3 polled investment analysts is to Buy stock in Xtant Medical Holdings Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.